Fisher & Paykel Healthcare Corporation Limited · NZX:FPH
Fisher & Paykel Healthcare — Shareholder Meeting (August 2015)
33 slides from Fisher & Paykel Healthcare's shareholder meeting presentation, Aug 27, 2015
Slide 1: Annual Shareholders' Meeting 2015
Annual Shareholders’ Meeting 2015 27 August 2015
Slide 2: Tony Carter - Chairman
< © 7 ® = O Tony Carter ykel Payl HEALTHCARE Fisher&
Slide 3: Your Board
3) ay i) i.) Websnt S A ag 4 N L \ ( Tony Carter Michael Daniell Roger France Lindsay Gillanders q ] 7 Arthur Morris Ger, di McBride Donal O’Dwyer Franceska Banga Fisher & Paykel HEALTHCARE
Slide 4: Agenda
Agenda CHAIR’S ADDRESS MANAGING DIRECTOR AND CHIEF EXECUTIVE OFFICER’S REVIEW ADDRESS FROM LEWIS GRADON FINANCIAL STATEMENTS RESOLUTIONS VOTING GENERAL QUESTIONS
Slide 5: Our Business
Our Business 10 MILLION+ PATIENTS TREATED DURING THE YEAR USING OUR MEDICAL DEVICES 10M+ $65 MILLION SPEND ON R&D NZ$65M R&D ENGINEERS AND SCIENTISTS WORKING IN R&D 430+ POTENTIAL GLOBAL MARKET OPPORTUNITY US$5B+ CURRENT RANGE OF PRODUCTS, ACCESSORIES AND PARTS 2,700+
Slide 6: Our Opportunity
Our Opportunity • Healthcare costs are increasing at a rapid rate. Total Expenditure on Health (US$/capita) $10,000 $9,000 Australia $8,000 Canada $7,000 Germany $6,000 Japan $5,000 New Zealand $4,000 Spain $3,000 United Kingdom $2,000 United States $1,000 $0 Source: OECD Health data 2000 2002 2004
Slide 7: 2015 Financial Snapshot
2015 Financial Snapshot NZ$ 113.2m 17% NZ$ 672.3m 13.8cps RECORD NET PROFIT GROWTH IN NET PROFIT RECORD OPERATING TOTAL DIVIDEND FOR THE AFTER TAX AFTER TAX REVENUE YEAR FULLY IMPUTED
Slide 8: Managing Director and CEO Succession
Managing Director and CEO Succession Michael Daniell Lewis Gradon
Slide 9: Our Team
Our Team 32 — Fisher & Paykel HEALTHCARE
Slide 10: Your Board
3) ay i) i.) Websnt S A ag 4 N L \ ( Tony Carter Michael Daniell Roger France Lindsay Gillanders q ] 7 Arthur Morris Ger, di McBride Donal O’Dwyer Franceska Banga Fisher & Paykel HEALTHCARE
Slide 11: Tony Carter - Chairman
< © 7 ® = O Tony Carter ykel Payl HEALTHCARE Fisher&
Slide 12: Michael Daniell – Managing Director & Chief Executive Officer
Michael Daniell – Managing Director & Chief Executive Officer
Slide 13: Continuous Product Improvement
Continuous Product Improvement 13
Slide 14: Serving More Patients & More Products for Each Patient
Serving More Patients & More Products for Each Patient Invasive Ventilation Adult Noninvasive Ventilation Optiflow Surgical Invasive Ventilation Neonatal T-Piece Resuscitation Optiflow Junior CPAP Therapy
Slide 15: Increase our International Presence
Increase our International Presence
Slide 16: A Proven Strategy
A Proven Strategy Continuous product improvement Serve more patient groups More products for each patient Increase our international presence
Slide 17: 2015 Financial Highlights
2015 Financial Highlights 12 Months Ended 12 Months Ended % Change 31 March 31 March 2014 2015 (NZ$m) (NZ$m) Operating revenue 623.4 672.3 +8% RAC operating revenue 336.9 368.2 +9% OSA operating revenue 270.0 291.1 +8% Net profit after tax 97.1 113.2 +17%
Slide 18: Respiratory and Acute Care (RAC)
Respiratory and Acute Care (RAC) 18
Slide 19: Optiflow Junior: Transforming Respiratory Support
Optiflow Junior: Transforming Respiratory Support
Slide 20: Obstructive Sleep Apnea (OSA)
Obstructive Sleep Apnea (OSA)
Slide 21: Outlook
Outlook First Half Operating Revenue ~NZ$380 million Net Profit after Tax ~NZ$60 million Full Year Expect at NZD:USD exchange rate of ~0.65 for the balance of the year Operating Revenue ~NZ$800 million Net Profit after Tax ~NZ$135 - NZ$140 million
Slide 22: Michael Daniell – Managing Director & Chief Executive Officer
Michael Daniell – Managing Director & Chief Executive Officer
Slide 23: Lewis Gradon – Chief Executive Officer Designate
Lewis Gradon – Chief Executive Officer Designate
Slide 24: Financial Statements
Financial Statements • Opportunity for shareholders to ask any questions specifically on the financial statements, the auditors’ report or the company’s 2015 annual report. • There will be an opportunity to ask any general questions once all items on the agenda have been considered.
Slide 25: Resolutions
Resolutions • Re-election of Directors • Auditor’s Remuneration • Issue of Performance Share Rights • Issue of Options
Slide 26: Resolution 1: Re-Election Of Director
Resolution 1: Re-Election Of Director • That Roger France, who retires by rotation and, being eligible, offers himself for re-election, be re-elected as a director of the Company. Proxies For Against Discretionary Votes 325,161,337 777,667 1,532,734 Percentage 99.35% 0.22% 0.43%
Slide 27: Resolution 2: Re-Election Of Director
Resolution 2: Re-Election Of Director • That Arthur Morris, who retires by rotation and, being eligible, offers himself for re-election, be re-elected as a director of the Company. Proxies For Against Discretionary Votes 352,900,604 52,537 1,513,611 Percentage 99.56% 0.01% 0.43%
Slide 28: Resolution 3: Auditor's Remuneration
Resolution 3: Auditor’s Remuneration • That the Directors be authorised to fix the fees and expenses of PricewaterhouseCoopers as the Company’s auditor. Proxies For Against Discretionary Votes 350,811,335 2,071,887 1,582,122 Percentage 98.97% 0.58% 0.45%
Slide 29: Resolution 4: Issue of Performance Share Rights
Resolution 4: Issue of Performance Share Rights • That approval be given for the issue of up to 50,000 performance share rights under the Fisher & Paykel Healthcare Performance Share Rights Plan to Mr Michael Daniell, Managing Director and Chief Executive Officer of the Company. Proxies For Against
Slide 30: Resolution 5: Issue of Options
Resolution 5: Issue of Options • That approval be given for the issue of up to 120,000 options under the Fisher & Paykel Healthcare 2003 Share Option Plan to Mr Michael Daniell, Managing Director and Chief Executive Officer of the Company. Proxies For Against Discretionary Votes 343,695,826 8,948,79
Slide 31: Voting
Voting • In respect of each resolution, please tick the “for”, “against” or “abstain” box. • Once you have completed your voting, please place your vote in a ballot box. • Please raise your hand if you require a pen. • Results will be announced to NZX and ASX as soon as they are available.
Slide 32: Fisher & Paykel Healthcare
Fisher & Paykel HEALTHCARE
Slide 33: Annual Shareholders' Meeting 2015
Annual Shareholders’ Meeting 2015 27 August 2015
Fisher & Paykel Healthcare — Shareholder Meeting (August 2015) on 6ix